Frank Sun is recommended for both private equity and M&A. For “major deals” Frank Sun is “very commercial” and “smart”, and he has “a good understanding of the business culture and environment in China.” The Legal 500 Asia-Pacific 2016

Qiuning (Frank) Sun

Hong Kong
  • 18th Floor, One Exchange Square
  • 8 Connaught Place, Central
  • Hong Kong
 
 

Frank Sun, a partner in the Hong Kong office of Latham & Watkins and a member of the Corporate Department, specializes in private equity investment and public and private M&A transactions. Mr. Sun regularly advises private equity funds and corporate clients in private equity investments, cross-border acquisitions, PIPEs, privatizations, and a wide range of other complex M&A transactions.

A native Mandarin speaker focusing on multijurisdictional work, Mr. Sun has practiced law in London, Beijing, New York, and Hong Kong. Prior to joining Latham, from 2012 he was a Hong Kong-based partner of another major international law firm.


Mr. Sun's recent experience includes advising:

  • L Catterton Asia on its US$175 million investment with JD.com in NASDAQ-listed Secoo Holding Limited, Asia's largest online integrated upscale products and services platform, through a subscription of convertible note and warrant
  • China Traditional Chinese Medicine Holdings Co. Limited on the placement of 604.3 million shares to Ping An Life Insurance Company of China for HKD2.68 billion
  • ORIX Asia Capital on its investment in Dianrong, a China-based online platform for borrowing and lending money
  • ORIX Asia Capital on its investment in WeCash, a China-based online credit evaluation platform
  • Carlyle Asia Partners on the sale of its controlling stake in Crystal Orange Hotel Holdings, a boutique hotel operator in China 
  • Orix Asia Capital in connection with the subscription of new shares and warrants issued by Hong Kong-listed United Photovoltaics Group Limited, which is seeking to raise equity and debt financing to redeem a certain portion of its outstanding convertible bonds
  • CITIC Capital Partners on its sale of a controlling stake in King Koil Shanghai Sleep System Co., Ltd to Advent International. King Koil China is a manufacturer and retailer of premium mattresses in China
  • Bain Capital, in its acquisition of a controlling interest in Asia Pacific Medical Group, a leading private hospital group, which provides a range of primary care and specialty services through a portfolio of hospitals and clinics in the PRC and other parts of Southeast Asia*
  • CITIC Capital in the acquisition of a minority interest in City Football Group Limited, owner of the Manchester City Football Club*
  • ORG Packaging Co. Ltd (SHE: 002701) in its acquisition of a 27% interest in CPMC Holdings Limited (HKSE:906) from COFCO Corporation for a total consideration of HKD1.6 billion (approximately US$205 million)*
  • The special committee of NASDAQ-listed eLong in connection with its acquisition by a consortium that includes affiliates of Tencent Holdings Limited, Ctrip.com, and certain other existing shareholders of eLong*
  • The special financing committee of NASDAQ-listed Sohu.com in connection with its evaluation of an investment proposal from Dr. Charles Zhang, Sohu.com’s chairman and chief executive officer*
  • Xinren Aluminum Holdings Limited (SGX: MN5), in its US$600 million structured financing composed of international syndicate loan facilities, secured convertible bonds, and warrants*
  • The Carlyle Group, in its investment in Beijing Ubox Technology & Trade Co., Ltd, a leading vending machine operator in China*
  • China Traditional Chinese Medicine Co. Limited (HKSE: 570) in its two “very substantial acquisitions” regulated by the Hong Kong Listing Rules and the related equity and debt financing transactions:
  • The US$1.43 billion acquisition of a 87.30% stake in Jiangyin Tianjiang Pharmaceutical Co. Ltd., the largest manufacturer of concentrated traditional Chinese medicine granules in China, from eight sellers, partly financed by HKD8.2 billion share subscriptions by certain existing shareholders and 26 institutional investors*   
  • The US$430 million acquisition of Tongjitang Chinese Medicine Company from Hanmax Investment Limited and Fosun Industrial Co., Limited*
  • Qihoo 360 Technology Co. Ltd. (NYSE: QIHU), a leading Internet company in China, in forming a strategic partnership with Hong Kong-listed Coolpad Group Limited (HKSE: 2369), a leading smartphone company in China*
  • CITIC Securities International Company Limited, in its investment in China Huarong Asset Management Co. Ltd as part of a US$2.35 billion pre-IPO placement by China Huarong to strategic investors*
  • Vipshop Holdings Limited (NYSE: VIPS), China's leading discount online retailer for brands, in its US$132.5 million acquisition of a 75% equity interest in Lefeng.com Limited, an online retailer of cosmetics and fashion products, and its US$55.8 million acquisition of a 23% equity interest in China-based cosmetics producer Ovation Entertainment Limited*
  • Ontario Teachers' Pension Plan in its US$175 million pre-IPO acquisition of a minority interest in a Chinese healthcare company through a subscription and purchase of shares*

*Matter handled prior to joining Latham

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.